Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Defying FDA: Shanghai Lab Gets Warning Letter But Won’t Relent
Oct 09 2019
•
By
Brian Yang
SHANGHAI INSTITUTE GETS WARNING LETTER AFTER DEFYING FDA INSPECTION • Source: Lab Website
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from China
More from Asia